We are live on ! Find out more
CTA

Chesley Taft & Associates Portfolio holdings

AUM $2.57B
1-Year Est. Return 22.93%
This Fund
S&P 500
This Quarter Est. Return
-13.44%
1 Year Est. Return
+22.93%
3 Year Est. Return
+80.85%
5 Year Est. Return
+97.37%
10 Year Est. Return
+353.09%
AUM
$1.47B
AUM Growth
-$244M
Cap. Flow
-$35.6M
Cap. Flow %
-2.43%
Top 10 Hldgs %
28.19%
Holding
302
New
8
Increased
82
Reduced
137
Closed
16

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$10.4M
2
INTC icon
Intel
INTC
+$9.67M
3
SWK icon
Stanley Black & Decker
SWK
+$5.68M
4
AMZN icon
Amazon
AMZN
+$3.11M
5
EFA icon
iShares MSCI EAFE ETF
EFA
+$2.73M

Sector Composition

Rank Sector Weight
1 Technology 18.32%
2 Healthcare 16.22%
3 Financials 10.4%
4 Consumer Staples 8.33%
5 Communication Services 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VB icon
76
Vanguard Morningstar Small-Cap ETF
VB
$82.2B
$4.65M 0.32%
26,409
-650
-2% -$126K
FISV
77
Fiserv Inc
FISV
$29.3B
$4.61M 0.31%
51,795
+1,675
+3% +$162K
VTI icon
78
Vanguard Morningstar Total Stock Market ETF
VTI
$683B
$4.54M 0.31%
24,054
+341
+1% +$70.1K
FTV icon
79
Fortive
FTV
$18.2B
$4.47M 0.3%
109,062
-385
-0.4% -$17K
SHM icon
80
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
$4.17M 0.28%
88,219
+250
+0.3% +$11.7K
CTSH icon
81
Cognizant
CTSH
$24.7B
$4.16M 0.28%
61,572
-1,270
-2% -$97.2K
LIN icon
82
Linde
LIN
$223B
$4.03M 0.27%
14,004
-375
-3% -$117K
LOW icon
83
Lowe's Companies
LOW
$122B
$4.01M 0.27%
22,980
-600
-3% -$116K
CCI icon
84
Crown Castle
CCI
$34B
$3.87M 0.26%
23,000
+635
+3% +$116K
IBB icon
85
iShares Biotechnology ETF
IBB
$9.37B
$3.86M 0.26%
32,777
+135
+0.4% +$16K
FLOT icon
86
iShares Floating Rate Bond ETF
FLOT
$10.3B
$3.83M 0.26%
76,725
+10,150
+15% +$511K
STIP icon
87
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
$3.81M 0.26%
37,566
+1,210
+3% +$125K
ADP icon
88
Automatic Data Processing
ADP
$107B
$3.8M 0.26%
18,076
ZTS icon
89
Zoetis
ZTS
$31.9B
$3.75M 0.26%
21,786
-337
-2% -$58.3K
VTIP icon
90
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$3.65M 0.25%
72,881
+1,000
+1% +$50.6K
CVS icon
91
CVS Health
CVS
$133B
$3.62M 0.25%
39,077
+344
+0.9% +$33.6K
DVN icon
92
Devon Energy
DVN
$50.6B
$3.58M 0.24%
65,043
+1,345
+2% +$87.8K
TMUS icon
93
T-Mobile US
TMUS
$189B
$3.51M 0.24%
26,064
+45
+0.2% +$5.87K
SHW icon
94
Sherwin-Williams
SHW
$87.6B
$3.44M 0.23%
15,364
-70
-0.5% -$18K
AMGN icon
95
Amgen
AMGN
$210B
$3.44M 0.23%
14,125
-20
-0.1% -$4.9K
HSY icon
96
Hershey
HSY
$35.8B
$3.42M 0.23%
15,900
+175
+1% +$38.1K
ABBV icon
97
AbbVie
ABBV
$430B
$3.39M 0.23%
22,132
+290
+1% +$44.3K
APTV icon
98
Aptiv
APTV
$9.88B
$3.29M 0.22%
36,910
-6,370
-15% -$650K
SYY icon
99
Sysco
SYY
$39.7B
$3.27M 0.22%
38,592
+2,232
+6% +$187K
TJX icon
100
TJX Companies
TJX
$174B
$3.26M 0.22%
58,441
-950
-2% -$57.5K

Similar funds

Chesley Taft & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Chesley Taft & Associates held 302 positions worth $1.47B, down 14% from $1.71B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Chesley Taft & Associates's Q2 2022 filing shows 8 new, 82 increased, 137 reduced and 16 closed positions. Its largest new stake was Cencora: 49,703 shares worth $7.03M. The largest sale was Costco, an estimated $10.4M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Chesley Taft & Associates's largest Q2 2022 buy was Cencora: 49,703 shares worth $7.03M.
  • Chesley Taft & Associates added most to NVIDIA in Q2 2022, an estimated $3.81M increase.
  • Chesley Taft & Associates's biggest Q2 2022 reduction was Costco, cutting an estimated $10.4M.
  • Chesley Taft & Associates fully exited Rockwell Automation in Q2 2022, selling an estimated $2.61M.
  • Chesley Taft & Associates's ten largest holdings make up 28% of its $1.47B portfolio in Q2 2022.
  • Chesley Taft & Associates opened 8 new positions and closed 16 in Q2 2022.
  • Chesley Taft & Associates's portfolio value fell 14% quarter-over-quarter to $1.47B.

Based on Chesley Taft & Associates's 13F filing for Q2 2022, filed 7 Jul 2022.